Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Joseph Ingrassia"'
Autor:
Kathir Balakumaran, Aadhar Patil, Shannon Marsh, Joseph Ingrassia, Chia-Ling Kuo, Daniel Louis Jacoby, Sabeena Arora, Richard Soucier
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 22, Iss , Pp 1-5 (2019)
Introduction: Heart failure is associated with recurrent hospitalizations and high mortality. Guideline directed medical treatment (GDMT), including beta blockers (BBs), angiotensin converting enzyme inhibitors (ACE-Is), angiotensin receptor blockers
Externí odkaz:
https://doaj.org/article/fcb6996c65ed420faf2868618a8be69f
Autor:
Abdelrahman Ali, Thomas Schirmer, Francis J. Kiernan, Bryan Piccirillo, Joseph Ingrassia, Talhat Azemi, Immad Sadiq, Daniel B. Fram, Asad Rizvi, Saurabh Joshi, Jeffrey Mather, Raymond G. McKay
Publikováno v:
Tex Heart Inst J
Background Previous studies have documented a negative impact of the COVID-19 pandemic on emergent percutaneous treatment of patients with ST-segment elevation myocardial infarction (STEMI), but few have examined recovery of healthcare systems in res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fbe321f0a83a7d608b7b75557fa22e0
https://europepmc.org/articles/PMC10178640/
https://europepmc.org/articles/PMC10178640/
Autor:
Martin B. Leon, Philip Green, Amir Masoumi, Shayan Nabavi Nouri, Shawn Gogia, Erika B. Rosenzweig, Mahesh V. Madhavan, Anthony Pucillo, Justin Fried, Matthew Finn, Cara I Agerstrand, Matthew Cohen, Sahil A. Parikh, Andrew J. Einstein, Nir Uriel, Andrew Eisenberger, Ajay J. Kirtane, Joseph Ingrassia, Koji Takeda, Daniel Brodie, Sanjum S. Sethi, Yevgeniy Brailovsky
Publikováno v:
Vascular Medicine (London, England)
Coronavirus disease 2019 (COVID-19) may predispose patients to venous thromboembolism (VTE). Limited data are available on the utilization of the Pulmonary Embolism Response Team (PERT) in the setting of the COVID-19 global pandemic. We performed a s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5444cc9cd91a789ade4ad48393c87a4
https://doi.org/10.1177/1358863x21995896
https://doi.org/10.1177/1358863x21995896
Publikováno v:
Journal of the American College of Cardiology. 81:3754
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbc207a3e7d61b37e3ba42dfbca6594b
https://doi.org/10.1016/s0735-1097(23)04198-0
https://doi.org/10.1016/s0735-1097(23)04198-0
Publikováno v:
Vascular and Endovascular Surgery. 53:325-336
Objective: The optimal antithrombotic regimen in peripheral arterial disease (PAD) is not known, leading to significant variations in antithrombotic treatment protocols in randomized trials and clinical practice. In device trials, antithrombotic regi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28aae61226dbac3fc8ac398db88df0ee
https://doi.org/10.1177/1538574419836316
https://doi.org/10.1177/1538574419836316
Autor:
Richard Soucier, Aadhar Patil, Shannon P. Marsh, Kathir Balakumaran, Sabeena Arora, Chia-Ling Kuo, Daniel Jacoby, Joseph Ingrassia
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 22, Iss, Pp 1-5 (2019)
International Journal of Cardiology. Heart & Vasculature
International Journal of Cardiology. Heart & Vasculature
Introduction: Heart failure is associated with recurrent hospitalizations and high mortality. Guideline directed medical treatment (GDMT), including beta blockers (BBs), angiotensin converting enzyme inhibitors (ACE-Is), angiotensin receptor blockers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f46718304fe11b5fa29ee39208c1ce6e
https://doi.org/10.1016/j.ijcha.2018.10.003
https://doi.org/10.1016/j.ijcha.2018.10.003
Publikováno v:
Journal of the American College of Cardiology. 80:B219
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eca0eea921263806e1cbde9bfcc552bc
https://doi.org/10.1016/j.jacc.2022.08.630
https://doi.org/10.1016/j.jacc.2022.08.630
Publikováno v:
Catheterization and Cardiovascular Interventions. 93:E98-E100
Coronary artery perforation (CAP) during percutaneous coronary intervention is a rare but serious complication. Treatment options of CAP include prolonged balloon inflation, covered stent, and coil embolization. Although most cases of CAP can be trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5463277ff591cdcf9acc6ac8a912cc33
https://doi.org/10.1002/ccd.27849
https://doi.org/10.1002/ccd.27849
Autor:
Sanjum S. Sethi, Ajay J. Kirtane, Alexander I. Murphy, Erika B. Rosenzweig, Robert Zilinyi, Joseph Ingrassia, Koji Takeda
Publikováno v:
Journal of the American College of Cardiology. 75:2978
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::48ea81bbe77078a17bf7273d78e4fbed
https://doi.org/10.1016/s0735-1097(20)33605-6
https://doi.org/10.1016/s0735-1097(20)33605-6
Publikováno v:
Journal of Clinical Medicine, Vol 7, Iss 9, p 228 (2018)
Journal of Clinical Medicine
Journal of Clinical Medicine
There has been increased awareness in the understanding and recognition of spontaneous coronary artery disease. Diagnosing this condition is of paramount importance as the treatment strategy differs greatly from traditional acute coronary syndrome pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad64ae8f4d439cbec5fb6d3cfa3a1d52
http://www.mdpi.com/2077-0383/7/9/228
http://www.mdpi.com/2077-0383/7/9/228